nvo market cap in febuary 2022

On February 28, 2022, Novo Nordisk A-S (NVO) had a market capitalization of $285.4B, based on 5.76B shares at a price of $49.52.

DATE CLOSE VOLUME OUTSTANDING MARKET CAP
February 28 2022
$49.52
2,163,000
5,762,000,000
$285,357,864,200.00
February 25 2022
$49.43
2,675,200
5,762,000,000
$284,803,559,800.00
February 24 2022
$47.60
2,918,600
5,762,000,000
$274,270,623,800.00
February 23 2022
$46.99
1,413,000
5,762,000,000
$270,750,618,000.00
February 22 2022
$47.74
1,595,200
5,762,000,000
$275,074,422,800.00
February 18 2022
$48.49
1,177,000
5,762,000,000
$279,425,885,200.00
February 17 2022
$49.28
1,578,200
5,762,000,000
$283,972,103,200.00
February 16 2022
$49.63
2,010,600
5,762,000,000
$285,967,483,800.00
February 15 2022
$48.76
1,900,000
5,762,000,000
$280,950,510,400.00
February 14 2022
$47.21
3,157,800
5,762,000,000
$272,025,172,400.00
February 11 2022
$47.58
3,747,400
5,762,000,000
$274,159,417,200.00
February 10 2022
$50.06
1,889,800
5,762,000,000
$288,434,196,000.00
February 09 2022
$50.95
2,559,600
5,762,000,000
$293,590,033,600.00
February 08 2022
$48.85
1,945,800
5,762,000,000
$281,477,157,200.00
February 07 2022
$48.95
2,094,800
5,762,000,000
$282,059,119,200.00
February 04 2022
$47.95
5,665,000
5,762,000,000
$276,266,004,400.00
February 03 2022
$50.33
3,937,800
5,762,000,000
$290,014,136,400.00
February 02 2022
$51.28
4,395,600
5,762,000,000
$295,447,126,200.00
February 01 2022
$49.36
4,038,200
5,762,000,000
$284,387,543,400.00